Skip to main content

Arterial Stiffness Progression Precedes Cardiac Damage in Teens

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 22, 2023 -- For adolescents, arterial stiffness progression precedes worsening structural and functional cardiac damage, according to a study published online Aug. 3 in Atherosclerosis.

Andrew O. Agbaje, M.D., M.P.H., from the University of Eastern Finland in Kuopio, and colleagues examined the temporal longitudinal associations of carotid-femoral pulse wave velocity (cfPWV) and carotid intima-media thickness (cIMT) with left ventricular hypertrophy (LVH) and diastolic dysfunction (LVDD) in a cohort of 1,856 adolescents (mean age, 17.7 years) followed for seven years.

The researchers found that the prevalence of LVH increased from 3.6 to 7.2 percent and that of LVDD increased from 11.1 to 16.3 percent during follow-up. In the total cohort, males, those with overweight/obesity, and normotensive individuals, high cfPWV progression was associated with worsening increased LV filling pressure E/e' wave ratio (hiLVFP). Similarly, in the total cohort, females, and individuals with normal weight, high cfPWV progression was associated with worsening hiLVFP. In the total cohort and those with overweight/obesity and elevated blood pressure/hypertension, high cIMT progression was associated with worsening LVH. In the total cohort, there was no association for cfPWV or cIMT progression with worsening increased relative wall thickness (hiRWT). Higher baseline cfPWV was associated with future LV mass indexed for height2.7 (LVMI2.7), RWT, LVD function E/A wave ratio, and LV filling pressure E/e' wave ratio in cross-lagged models. The direct associations of cumulative cfPWV with cumulative LVMI2.7 were mediated by cumulative increased systolic blood pressure and insulin resistance (34.3 and 15.1 percent mediation, respectively).

"Experimental and clinical intervention studies are urgently needed on comprehensive approaches to treating and reversing arterial stiffness from adolescence," Agbaje said in a statement. "At least, targeting blood pressure and insulin resistance leaves the problem half-solved."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023

WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.